Technology | 2021.07.30
Omega Therapeutics Announces Pricing of Initial Public Offering
CAMBRIDGE, Mass, July 29, 2021 /PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a development-stage biotechnology company leveraging its OMEGA Epigenomic Programming™ platform to harness the power of epigenetics to develop a new class of DNA-sequence-targeting,...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]public-offering-301344870.html
